Vident Investment Advisory, LLC Edwards Lifesciences Corp Transaction History

Vident Investment Advisory, LLC

$0
Q3 2023

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $1.5 Million - $1.73 Million	-18,364 Reduced 22.58%	62,953 $5.94 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $5.3 Million - $6.04 Million	71,423 Added 721.88%	81,317 $6.73 Million
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $550,634 - $704,941	-8,062 Reduced 44.9%	9,894 $738,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $395,705 - $515,421	4,804 Added 36.53%	17,956 $1.17 Million
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $275,589 - $408,668	3,186 Added 31.97%	13,152 $1.25 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $108,587 - $136,682	-1,065 Reduced 9.65%	9,966 $1.17 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $769,799 - $945,731	-7,237 Reduced 39.62%	11,031 $1.43 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $737,555 - $879,749	7,167 Added 64.56%	18,268 $2.07 Million
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $1.8 Million - $2.25 Million	-21,486 Reduced 65.93%	11,101 $1.15 Million
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $1.22 Million - $1.4 Million	15,481 Added 90.5%	32,587 $2.73 Million
Q4 2020 Feb 08, 2021	SELL	$71.69 - $91.23 $22,152 - $28,190	-309 Reduced 1.77%	17,106 $1.56 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $65,846 - $85,691	980 Added 5.96%	17,415 $1.39 Million
Q2 2020 Jul 17, 2020	BUY	$57.54 - $76.95 $870,062 - $1.16 Million	15,121 Added 1150.76%	16,435 $1.14 Million
Q1 2020 May 12, 2020	BUY	$52.41 - $81.0 $68,866 - $106,434	1,314 New	1,314 $248,000
Q1 2019 May 08, 2019	SELL	$47.89 - $64.05 $98,797 - $132,135	-2,063 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $100,292 - $123,047	-2,161 Reduced 51.16%	2,063 $316,000
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $193,036 - $245,118	4,224 New	4,224 $735,000
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $382,856 - $462,674	-9,019 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$37.19 - $47.45 $55,338 - $70,605	-1,488 Reduced 14.16%	9,019 $1.25 Million
Q4 2017 Feb 15, 2018	SELL	$33.79 - $39.39 $24,666 - $28,754	-730 Reduced 6.5%	10,507 $1.18 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $407,790 - $436,332	11,237	11,237 $1.23 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

Vanguard Group Inc Valley Forge, PA

53.6M
Shares

$3.51 Billion
0.1% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.34 Billion
0.11% of portfolio
State Street Corp Boston, MA

26M
Shares

$1.7 Billion
0.11% of portfolio
Alliancebernstein L.P. New York, NY

20.3M
Shares

$1.33 Billion
0.68% of portfolio
Wellington Management Group LLP Boston, MA

16.9M
Shares

$1.11 Billion
0.29% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Account